A new study has been released and the information is intended to help men with erectile dysfunction issues the treatment options and opportunities that are available on the market, the study also effectively identifies the target patient market, and treatment possibilities.
The examine enables executives to estimate Erectile disorder marketplace capacity, investigate unmet need, broaden drug forecasting fashions, and build population-primarily based fitness management frameworks.
What was observed, measures key indicators consisting of the prevalence of Erectile dysfunction derived from epidemiological analysis, percent of sufferers identified with an erectile sex disorder, and percent of sufferers dealt with with a therapy.
Excluding the popular cures on the market today like; Viagra, Cialis, Cialis for Daily Use, Levitra and similar drugs, there are two main options that show some hope for men that they can restore some level of prior function.
An alternative erectile dysfunction treatment available that men might want to consider is an inflatable penial implant. – including a reservoir of water and a pump – the surgery can be complicated. The implanted pump can also be awkward for the user, with the potential to cause medical complications, including water leakage from the internal reservoir.
A new treatment option available was just announced, Mexico has awarded the company Apricus and partner, Ferring Pharmaceuticals, approval start marketing Vitaros®, an is a manual topical cream designed to be applied directly to the penis to treat patients suffering from erectile dysfunction symptoms.
There are also 26 other countries in where the erection product Vitaros® has been allowed for purchase, including Argentina, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Lebanon, Luxembourg, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Spain, Sweden, Switzerland and the United Kingdom.